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Introduction {#sec001}
============

Esophageal cancer ranks the eighth leading cause of cancer-related deaths and the tenth most common malignancy worldwide.\[[@pone.0155903.ref001]\] And China is the country with top prevalence and mortality of esophageal cancer, especially esophageal squamous cell carcinoma (ESCC). Malnutrition commonly observed in esophageal cancer patients,\[[@pone.0155903.ref002]\] and the presence of malnutrition is associated with poor clinical outcomes: impairing quality of life, performance status, immune functions, muscle function, and even survival in esophageal cancer patients. \[[@pone.0155903.ref003]\] It has been recognized that age is an independent predictor of poor clinical outcome and nutritional disorders,\[[@pone.0155903.ref004], [@pone.0155903.ref005]\] but it is frequently unrecognized.

The GNRI, a screening index of nutrition-related risk, is an objective and simple nutritional assessment option determined by only serum albumin and body weight. This index was established by Bouillanne et al.\[[@pone.0155903.ref006]\] It has been proposed for the evaluation of at-risk elderly hospital patients,\[[@pone.0155903.ref007]--[@pone.0155903.ref011]\] chronic obstructive pulmonary disease,\[[@pone.0155903.ref012]\] hemodialysis patients,\[[@pone.0155903.ref013]--[@pone.0155903.ref017]\] and [cardiovascular](http://www.ncbi.nlm.nih.gov/pubmed/24365385) patients.\[[@pone.0155903.ref018]--[@pone.0155903.ref020]\] To date, no long-term population-based cohort studies have estimated the association between the GNRI and the survival of ESCC patients. Thus, the present study aimed to investigate whether the GNRI is a reliable predictor of the survival in elderly ESCC patients who undergone radiotherapy.

Methods and Material {#sec002}
====================

Participants {#sec003}
------------

The participants should meet all the following criteria: (1) aged 60 years old or older; (2) pathological diagnosis as ESCC; (3) conscious, able to stand and answer questions; (4) received radiotherapy only; The exclusion criteria for patients were as follows: (1) a pathological diagnosis of esophageal cancer other than ESCC; (2) aged less than 60 years old; (3) presence of malnutrition that resulted from other disease; (4) received surgery or chemotherapy other than radiotherapy.

The 239 ESCC patients aged 60 and over admitted consecutively from January 2008 to November 2014 in the Department of Radiotherapy, Henan Tumor Hospital(Affiliated Tumor Hospital of Zhengzhou University), Zhengzhou, Henan, China were selected. The project was approved by the ethical committee Zhengzhou University. And all the participants signed the informed consent.

Nutritional assessment by GNRI {#sec004}
------------------------------

The data of weight, height, and serum albumin of the subjects were collected. Nutrition-related complications were assessed according to GNRI.\[[@pone.0155903.ref006], [@pone.0155903.ref021]\] The GNRI, combining two nutritional indicators: albumin and actual weight compared with ideal body weight, was developed by modifying the nutritional risk index for elderly patients.\[[@pone.0155903.ref006], [@pone.0155903.ref007], [@pone.0155903.ref011]\] The GNRI formula is as follows: $$\text{GNRI~} = \ \left\lbrack {1.487 \times \text{~serum~albumin~}\left( {\text{g}/\text{L}} \right)\  + \ }\lbrack \right.41.7 \times \text{~present}/\text{usual~weight~}\left( \text{kg} \right)\rbrack$$

The participants were classified according to the following cut-offs: high risk, \<92; moderate risk, 92 to 98; no risk, \>98\[[@pone.0155903.ref021]\].

Similarly to previous study,\[[@pone.0155903.ref007], [@pone.0155903.ref011], [@pone.0155903.ref022]--[@pone.0155903.ref024]\] we utilized the modified categories of GNRI: severe risk (GNRI \< 92) and moderate risk (GNRI 92--98) categories were included into one single category, as both groups have been demonstrated to present a high risk of complications.\[[@pone.0155903.ref006]\]

Follow-up {#sec005}
---------

The primary study outcome was overall survival time, and the second outcomes of follow-up evaluations were lymph node metastasis and radiation complication. Follow-up evaluations were performed every 3 months for the first year, every 6 months for the second year, and yearly thereafter. Follow-up was performed until patient death, or until October 2015, which was the cut-off date for this study.

Statistical Analysis {#sec006}
--------------------

The Analysis of variance (ANOVA) was used to examine the differences of continuous variable (age), and the chi-square test was used to explore the difference of categorical variables (including sex, differentiation, tumor location, tumor stage, dose radiotherapy, lymph node metastasis, and radiation complication). The Kaplan--Meier method with Log-rank test was used to estimate survival curves. Univariable Cox regression analysis was used to identify variables associated with overall survival time. Variables with a *P* \<0.05 on univariable analysis were further assessed with a multivariable Cox regression model. SPSS 21 software (IBM Corp, Armonk, NY) was used for the statistical analysis. The level of significance was established as a two-sided *P* value 0.05.

Results {#sec007}
=======

Patient characteristics {#sec008}
-----------------------

One hundred and fifty males and 89 females, whose ages ranged from 60 to 88 years (mean age of 67.9±5.9 years at diagnosis), were included in our study. According to the TNM categories, 22 patients (7%) were classified as stage I, 138(43.9%) were classified as stage II, 54(17.2%) were classified as stage III, and 25(8%) were classified as stage IV. 71(29.7%) patients received radiation doses of ≤50Gy and 168(70.3%) received radiation doses of \>50Gy. 82(34.3%) patients had metastatic lymph nodes, and 129(53.9%) patients had complication of radiotherapy.

By October, 2015, 226 participants had been followed up.13 patients were lost to follow-up, the follow-up rate was 94.6%. The mean and median survival times were 40.4 months and 33 months, respectively. The cumulative survival probabilities at 1, 3, and 5 years of the 239 participants were 72.6%, 48.9%, and 22.7%, respectively.

As shown in [Table 1](#pone.0155903.t001){ref-type="table"}. 184 patients (76.9%) took no nutritional risk, 32 patients (13.4%) took moderate risk of malnutrition, and 23 patients (9.7%) took a high risk of malnutrition. There were no statistically significant differences in the rate of sex, differentiation, tumor location, tumor stage, dose radiotherapy, lymph node metastasis, diabetes, white blood cell count(WBC), neutrophils, and lymphocyte among different GNRI categories(*P*\>0.05). However, the age, weight loss, radiation complication, and serum albumin differentiate among different GNRI categories (*P*\<0.05).

10.1371/journal.pone.0155903.t001

###### Characteristics of the participants according to geriatric nutritional risk index categories.

![](pone.0155903.t001){#pone.0155903.t001g}

  Variable                   Total(n = 239)   Geriatric Nutritional Risk Index (GNRI)   *P*                       
  -------------------------- ---------------- ----------------------------------------- ----------- ------------- -------
  Age at diagnosis (years)   239              71.3±6.1                                  65.8±4.6    67.8±5.9      0.003
  Sex                                                                                                             0.505
  Male                       150              17(11.3%)                                 20(13.3%)   113(75.3%)    
  Female                     89               6(6.7%)                                   12(13.5%)   71(79.8%)     
  Differentiation                                                                                                 0.419
  Well                       35               5(14.3%)                                  6(17.1%)    24(68.6%)     
  Moderate                   51               2(3.9%)                                   8(15.7%)    41(80.4%)     
  Poor                       153              16(10.5%)                                 18(11.8%)   119(77.8%)    
  Tumor location                                                                                                  0.117
  Upper esophagus            68               3(4.4%)                                   9(13.2%)    56(82.4%)     
  Middle esophagus           143              14(9.8%)                                  21(14.7%)   108(75.5%)    
  Lower esophagus            28               6(21.4%)                                  2(7.1%)     20(71.4%)     
  Tumor stage                                                                                                     0.886
  I                          22               1(4.5%)                                   2(9.1%)     19(86.4%)     
  II                         138              12(8.7%)                                  19(13.8)    107(77.5%)    
  III                        54               7(13%)                                    7(13%)      40(74%)       
  IV                         25               3(12%)                                    4(16%)      18(72%)       
  Dose radiotherapy (Gy)                                                                                          0.436
  ≤50                        71               9(12.7%)                                  11(15.5%)   51(71.8%)     
  \>50                       168              14(8.3%)                                  21(12.5%)   133(79.2%)    
  Lymph node metastasis                                                                                           0.349
  Yes                        82               11(13.4%)                                 10(12.2%)   61(74.4%%)    
  No                         157              12(7.6%)                                  22(14.1%)   123(78.3%%)   
  Radiation complication                                                                                          
  Radiation esophagitis                                                                                           0.000
  No                         115              9(7.8%)                                   11(9.6%)    95(82.6%)     
  Grade 1--2                 82               3(3.7%)                                   11(13.4%)   68(82.9%)     
  Grade 3--4                 42               11(26.2%)                                 10(23.8%)   21(50.5%)     
  Bone marrow suppression                                                                                         0.000
  No                         118              11(8.5%)                                  10(9.3%)    97(82.2%)     
  Grade 1--2                 90               4(4.4%)                                   15(16.7%)   71(78.9%)     
  Grade 3--4                 31               9(29.0%)                                  6(19.4%)    16(51.6%)     
  Diabetes                                                                                                        0.499
  Yes                        21               3(9.2%)                                   14(12.8%)   14(78.0%)     
  No                         218              20(14.3%)                                 28(19.0%)   170(66.7%)    
  Albumin                    239              34.5±10.66                                36.8±1.66   42.7±2.69     0.000
  WBC(×10^9^/L)              239              6.48±2.37                                 7.03±2.57   6.58±1.26     0.568
  Neutrophils(×10^9^/L)      239              4.02±2.05                                 4.37±2.22   3.93±1.67     0.429
  Lymphocyte(×10^9^/L)       239              1.67±0.69                                 1.83±0.49   1.94±0.83     0.270
  Weight loss(%)             239              19.3±19.7                                 2.19±4.20   0.58±2.22     0.000

This ordered logistic regression analysis identified only independent predictor for nutritional index categories-weight loss ([Table 2](#pone.0155903.t002){ref-type="table"}).

10.1371/journal.pone.0155903.t002

###### Results of Ordered Logistic Regression Analysis for Nutritional Risk Index Categories by Forward Selection.

![](pone.0155903.t002){#pone.0155903.t002g}

  Variable                            Coefficient   Standard Error   Wald     *P*     95%*CI*   
  ----------------------------------- ------------- ---------------- -------- ------- --------- --------
  Constant 1                          -7.305        2.466            8.772    0.003   -12.139   -2.471
  Constant 2                          -5.748        2.442            5.540    0.019   -10.535   -0.962
  Age at diagnosis(year)              -0.038        0.021            3.229    0.072   -0.080    0.003
  Albumin                             -0.039        0.047            0.685    0.408   -0.132    0.053
  Weight loss(%)                      18.965        3.916            23.460   0.000   11.291    26.639
  Bone marrow suppression(Grade1-2)   -0.235        0.897            0.069    0.793   -1.993    1.522
  Bone marrow suppression(Grade3-4)   -0.407        0.830            0.241    0.623   -2.034    1.219
  Radiation esophagitis(Grade1-2)     0.608         0.852            0.509    0.476   -1.062    2.278
  Radiation esophagitis(Grade3-4)     -0.559        0.835            0.447    0.504   -2.196    1.079

Univariate analysis for the survival of elderly ESCC patients {#sec009}
-------------------------------------------------------------

Univariate analysis was performed to identify the factors predicting the survival of elderly ESCC patients who undergone radiotherapy. Survival curves were significantly stratified by GNRI categories ([Fig 1](#pone.0155903.g001){ref-type="fig"}). The median survival of the non-nutritional risk group was twice longer than that of the patients with high-nutritional risk (38 months vs. 20 months). Compared with the patients taking no nutritional risk, the risk of death increased by 66.7% (HR = 1.667, 95%CI: 1.011--2.750) for the patients with moderate risk and 135% (HR = 2.350, 95%: 1.331--4.150) for the patients with high risk, respectively. Compared with those patients who had no lymph node metastasis, the patients with lymph node metastasis had higher risk of death (HR = 2.086, 95%CI: 1.464--2.972). Patients with radiation complications had significantly poorer outcomes compared with those patients having no radiation complications (HR = 1.737, 95%CI: 1.213--2.487). We also analyzed whether the poor survival of elderly ESCC patients was caused by other underlying factors, including age, sex, differentiation, tumor location, tumor stage, and the dose of radiotherapy. No significant differences between these subgroups were found ([Table 3](#pone.0155903.t003){ref-type="table"}).

![Kaplan--Meier survival curves showing patient overall survival stratified by GNRI categories (high risk, \<92; moderate risk, 92 to 98; no risk, \>98.](pone.0155903.g001){#pone.0155903.g001}

10.1371/journal.pone.0155903.t003

###### Univariate analysis of factors associated with overall survival.

![](pone.0155903.t003){#pone.0155903.t003g}

  Variable                 No.   Median survival time (month)   HR      95% CI         *P* Value
  ------------------------ ----- ------------------------------ ------- -------------- -----------
  Age at diagnosis                                                                     
  \<70(reference)          151   36                             1                      
  ≥70                      88    27                             1.144   0.794--1.648   0.470
  Sex                                                                                  
  Male(reference)          150   27                             1                      
  Female                   89    40                             0.833   0.697--1.002   0.052
  Differentiation                                                                      
  Well(reference)          35    40                             1                      
  Moderate                 51    47                             0.624   0.348--1.119   0.114
  Poor                     153   30                             0.762   0.465--1.249   0.218
  Tumour location                                                                      
  Upper(reference)         68    29                             1                      
  Middle                   143   36                             1.052   0.566--1.957   0.872
  Lower                    28    27                             1.022   0.578--1.809   0.940
  Tumour stage                                                                         
  I-II(reference)          160   40                             1                      
  III-IV                   79    27                             1.145   0.787--1.665   0.480
  Dose radiotherapy (Gy)                                                               
  ≤50(reference)           71    30                             1                      
  \>50                     168   36                             0.985   0.675--1.436   0.936
  Lymph node metastasis                                                                
  No(reference)            157   40                             1                      
  Yes                      82    15                             2.086   1.464--2.972   0.000
  Radiation complication                                                               
  No(reference)            110   40                             1                      
  Yes                      129   22                             1.737   1.213--2.487   0.003
  Diabetes                                                                             
  No(reference)            218   35                             1                      
  Yes                      21    22                             1.333   0.735          2.418
  GNRI                                                                                 
  \>98(reference)          184   38                             1                      
  92--98                   32    23                             1.667   1.011--2.750   0.045
  \<92                     23    10                             2.350   1.331--4.150   0.003

Abbreviations: HR: hazard ratio; CI: confidence intervial

The multivariable analysis with Cox regression {#sec010}
----------------------------------------------

In order to exclude the impact of some confounders on overall survival time, variables with a *P*\<0.05 on univariable analysis were further assessed with a multivariable Cox regression model. We found that GNRI, lymph node metastasis, and radiation complications were independent predictors of overall survival time. Compared with the non-nutritional risk group, the risk of death increased by 68.8% (HR = 1.688, 95%CI: 1.019--2.798) for moderate risk group and 169.9% (HR = 2.699, 95%CI: 1.512--4.819) for high risk group, respectively. ([Table 4](#pone.0155903.t004){ref-type="table"})

10.1371/journal.pone.0155903.t004

###### Multivariable Cox Regression (Outcome Death).

![](pone.0155903.t004){#pone.0155903.t004g}

  Variable                              β       SE      Wald     *P*     HR      95%CI
  ------------------------------------- ------- ------- -------- ------- ------- --------------
  GNRI                                                                           
  \>98(reference)                                       13.685   0.001           
  92--98                                0.524   0.258   4.13     0.042   1.688   1.019--2.798
  \<92                                  0.993   0.296   11.273   0.001   2.699   1.512--4.819
  Lymph node metastasis (Yes vs. No)    0.691   0.184   14.06    0.000   1.996   1.391--2.864
  Radiation complication (Yes vs. No)   0.513   0.188   7.456    0.006   1.671   1.156--2.415

Abbreviations: GNRI: Geriatric Nutritional Risk Index; HR: hazard ratio; CI: Confidence Interval

Discussion {#sec011}
==========

It is reported that clinical malnutrition can make it more difficult to recovery from disease, trauma and surgery. Malnutrition is associated with increased morbidity and mortality in both chronic and acute conditions. As a result, the duration of hospital treatment is significantly longer in malnourished patients. Hence, the costs is higher.\[[@pone.0155903.ref004]\] Elderly patients frequently have compromised nutritional status and are also vulnerable to cancer-related deaths.

To our knowledge, this is the first study to evaluate the impact of GNRI on the survival of elderly ESCC patients treated with radiotherapy. We found that patients with malnutrition before radiotherapy take significantly higher risk of mortality. These results suggest that the early nutrition evaluation using GNRI is not only helpful to predict mortality in patients with ESCC, but also an important basis for individualized nutrition and health care, which may be beneficial to these patients.

Due to the diversity of influencing factors of nutritional status in patients with cancer, it is difficult to study the nutritional status of cancer patients.\[[@pone.0155903.ref025]\] Therefore, whether malnutrition is a potential predictor of surviving less is unclear. In the present study, we performed multivariate analyses adjusting for potential covariates and found that malnutrition is an independent risk factor for death. Compared with the non-nutritional risk group, the risk of death had increased by 68.8% for moderate risk group and 169.9% for high risk group, respectively.

The main advantages of the GNRI are the lower bias associated with past unintentional weight loss investigations and less requirements of participation from participants.\[[@pone.0155903.ref021]\] Previous studies have demonstrated its prognostic role in rehabilitative, sub-acute, and long-term care settings.\[[@pone.0155903.ref006], [@pone.0155903.ref021]\] However, there is no study to explore the association between GNRI and ESCC survival. To date, there was only a small study that showed an association between GNRI and the short-term postoperative respiratory complications in patients with esophageal cancer undergoing esophagectomy and gastric tube reconstruction.\[[@pone.0155903.ref026]\] In the present study, the outcomes were overall survival time, which represents a long-term prognosis of ESCC.

Cereda E et al. found that GNRI is a good predictor of length of staying and in-hospital weight loss in elderly patients.\[[@pone.0155903.ref011]\] Matsumura et al. suggested that GNRI had a more close relation with exercise tolerance and might be a useful nutritional assessment scale for elderly patients with [chronic obstructive pulmonary disease](http://apps.webofknowledge.com/OneClickSearch.do?product=UA&search_mode=OneClickSearch&excludeEventConfig=ExcludeIfFromFullRecPage&SID=T1EIlLDyEpMax4IkmOL&field=TS&value=Chronic+obstructive+pulmonary+disease+%28COPD%29&uncondQuotes=true&cacheurlFromRightClick=no) (COPD).\[[@pone.0155903.ref012]\] Besides, GNRI is a higher prognostic value for predicting nutritional-related complications in hospitalized elderly patients.\[[@pone.0155903.ref007]\] In a prospective cohort study of 332 patients, GNRI is a strong predictor of overall mortality in hemodialysis patients.\[[@pone.0155903.ref027]\] At the present, we found that GNRI is an independent predictor of overall survival time in elderly ESCC patients, which adds new evidence for the relationship between GNRI and outcomes of elderly patients.

This study had several limitations. Firstly, this study only included elderly ESCC patients who undergone radiotherapy, and the results may not represent a general population of older ESCC patients undergoing other therapy methods(such as esophagectomy and chemotherapy). Secondly, it was a single-center study with a relatively small sample size (only 239 cases were included). Larger sample clinical analysis is required for further study. Finally, albumin can be affected by non-nutritional factors such as inflammatory state, further studies adjusting factors accounting for inflammatory background (such as C-reactive protein) might probably improve our findings.

Conclusion {#sec012}
==========

In conclusion, the present study suggests that the GNRI is a simple and effective tool to predict the overall survival time in elderly ESCC patients treated with radiotherapy. Compared with the non-nutritional risk group, the risk of death had increased by 68.8% for moderate risk group and 169.9% for high risk group, respectively.

Supporting Information {#sec013}
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